ESC Leitlinie Infective Endocarditis (Guidelines on Prevention, Diagnosis and Treatment of), engl.

Year of publication: 2015

Editing medical society(ies):
European Society of Cardiology (ESC)

Other medical societies involved: 32

ESC Guidelines


List of evaluated guidelines

Evaluation by Leitlinienwatch

27.02.16


PTs.

Criterion
2

Transparency

European Society of Cardiology (ESC) guideline outside the German AWMF register (http://eurheartj.oxfordjournals.org/content/36/44/3075). Detailed information regarding potential conflicts of interest for each author is published on the ESC homepage: http://www.escardio.org/static_file/Escardio/Guidelines/Publications/IE/DOI_Summary_2015_IE.pdf
There is no transparent evaluation of conflicts of interest as part of the guideline process.
0

Composition of the Guideline Working Group

13 out of 20 authors in the guideline working group declare financial conflicts of interest.
0

Independence of the Coordinators/Chairs/Lead AuthorsUnabhängigkeit der Vorsitzenden/federführenden Autoren

Both lead authors declare financial conflicts of interest.
0

Abstention from Voting

There is no documented rule regarding abstentions from voting in authors with COI.
0

External Review of the Guideline

An external review via a publicly accessible website did not occur.
1

Bonus Points

The guidelines were assessed internally by 21 reviewers. These reviewers also declared their conflicts of interest. How this group was recruited is not documented, however.

Explanations to the evaluation criteria

Overall score

3

Good! (11-18)

Warning! (6-10)

Needs reform! (0-5)

Comment

The ESC guidelines also apply in Germany, as the Deutsche Gesellschaft für Kardiologie (German Society of Cardiology) has adopted the ESC guidelines. A large number of the authors of the ESC guidelines “Infective Endocarditis” declare financial conflicts of interest. A standard guideline report that would explain the rules regarding abstention from voting, study evaluation methods, recruitment of the guideline working group, and the review process is not available. We would like to note that financial conflicts of interest probably only play a minor role in these guidelines, as the guidelines primarily recommend off-patent medications and surgical or imaging procedures.

Note: This evaluation was conducted with due care on the basis of the published guideline. Should you still discover an error, please contact us at info@leitlinienwatch.de.